FindTrial
Sign In

Infiltration of an adjuvant drug with local anaesthetic for post operative pain relief in lower abdominal surgries

Post operative analgesic efficacy of dexmedetomidine with bupivacaine in wound infiltration for lower abdominal surgries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/08/020674
Enrollment
75
Registered
2019-08-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: wound infiltration: Group B dose bupivacaine 0.25% + 2 cc ns total 20 cc To be infiltrated in the wound infiltration before wound closure via 23 G hypodermic needle And post operative a

Sponsors

Department of Health and Family Welfare
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA I & II SCHEDULED FOR LOWER ABDOMINAL SURGERIES

Exclusion criteria

Exclusion criteria: Patient refusal Patients with H/o cardiac, respiratory, renal or hepatic dysfunction or failure Coagulation disorders Psychological disorders Allergy to study medications Chronic use of pain medications Adrenoreceptors agonists or antagonists Patients with H/o Motion sickness Patient with Body mass index > 35 Women who are in menstruation.

Design outcomes

Primary

MeasureTime frame
duration and efficiency of post operative analgesia after wound infiltrationTimepoint: duration of post operative analgesia 48 hour after wound infiltration—

Secondary

MeasureTime frame
The effectiveness and onset of post operative analgesia,sedation and complications if any.Timepoint: 48 hour post operative period—

Countries

India

Contacts

Public ContactDr Kiran Patel

B.J. Medical College

kiru4576@yahoo.com9428804290

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026